Kit for childhood acute lymphoblastic leukemia genotyping
An acute lymphocyte and genotyping technology, applied in the field of biomedicine, can solve the problems of cumbersome operation steps, unstable reaction system, and low sensitivity, and achieve the effects of stable experimental system, improved sensitivity, and easy operation
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0033] Embodiment 1, collection, acquisition and processing of clinical samples
[0034] 1. Collection of clinical specimens
[0035] Bone marrow samples from 219 newly diagnosed children with ALL who were treated in Beijing Children's Hospital between May 2011 and August 2016 were collected (with the consent of the children themselves or their guardians, and signed informed consent).
[0036] 2. Diagnosis and classification of newly diagnosed children with acute lymphoblastic leukemia
[0037] 219 children with ALL were diagnosed as ALL by MICM classification, including 16 children with T-ALL (T lineage ALL, T-ALL) and children with progenitor B lineage ALL (pro-B-ALL) 9 cases, 3 cases of pre-B-ALL (precursor Blineage ALL, pre-B-ALL) children, 191 cases of common B-ALL (common B lineage ALL, c-B-ALL) children. The diagnostic and typing criteria were based on the national unified standard (Suggestions for Diagnosis and Treatment of Children with Acute Lymphoblastic Leukemia....
Embodiment 2
[0067] Embodiment 2, GeXP multiple gene genetic analysis system detection
[0068] 1. Synthesis of primers
[0069] 57 typing genes, 3 internal reference genes (B2M, PSMC4 and GUSB) and 2 quality control genes (pcDNA3.1(+) and Kan R ) primer sequence has been disclosed in the Chinese invention patent document CN 104059970 B, and the specific information is shown in Table 3.
[0070] Table 3. Primer sequences and grouping of 57 typing genes, 3 internal reference genes and 2 quality control genes
[0071]
[0072]
[0073] Note: Sequence 1-126 is the primer sequence after adding the universal Tag sequence; the fragment size* refers to the size of the amplified fragment after removing the universal Tag sequence.
[0074] 2. GeXP reaction system optimization
[0075] 1. Preparation of mixed RNA samples
[0076] Randomly take RNA samples from 16 newly diagnosed ALL children numbered 1-16 in Table 4, and first use DNA / RNase-free H 2 O were diluted to 50ng / μL, and then mix...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


